Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic
Familial Cancer · 26.06.2026 · 25 (3)
DOI: 10.1007/s10689-026-00575-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 26.06.2026. Verfasst von Alex Raghunandan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College, New York, NY, USA. Hauptthemen laut MEDLINE: Genetic Testing, Quality Improvement, Health Services Accessibility, Gynecology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Most individuals with hereditary cancer syndromes remain undiagnosed and cannot benefit from cancer mitigation strategies. Mainstreaming, or the process of integrating genetic testing into routine care, can expand access, but implementation in primary care settings has proven challenging. In a quality improvement initiative, stakeholder feedback guided the development of care algorithms, patient/provider resources, and streamlined lab workflows for mainstreaming in an urban, diverse, Medicaid-predominant benign gynecology clinic. The mainstreaming initiative was launched in December 2024; over the subsequent four months, 274 consecutive patients presented for gynecologic care and 32 (11.7%) completed same-day genetic testing. This model demonstrates a feasible and scalable approach to integrating genetic testing into benign gynecology clinics serving diverse patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medical College, New York, NY, USA.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, 525 East 68th Street, Suite J-130, New York, NY, 10065, USA.
- Genetics and Personalized Cancer Prevention Program, Weill Cornell Medicine, New York, NY, USA.
- Division of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.
- Division of Gastroenterology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, 525 East 68th Street, Suite J-130, New York, NY, 10065, USA. mkf2002@med.cornell.edu.
Zitieren
APA
Raghunandan, A., Davis-Rivera, L., Ahsan, M. D., Chandler, I. R., Lopez, S., Ozarowski, A. L., Primiano, M., Pardo, C., Sharaf, R. N., & Frey, M. K. (2026). Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic. Familial Cancer, 25(3). https://doi.org/10.1007/s10689-026-00575-y
Vancouver
Raghunandan A, Davis-Rivera L, Ahsan MD, Chandler IR, Lopez S, Ozarowski AL, et al. Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic. Familial Cancer. 2026;25(3). doi:10.1007/s10689-026-00575-y
BibTeX
@article{Raghunandan2026,
author = {Raghunandan, Alex and Davis-Rivera, Lauren and Ahsan, Muhammad Danyal and Chandler, Isabelle R and Lopez, Steve and Ozarowski, Amanda Laterza and Primiano, Michelle and Pardo, Christina and Sharaf, Ravi N and Frey, Melissa K},
title = {Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic},
journal = {Familial Cancer},
year = {2026},
volume = {25},
number = {3},
doi = {10.1007/s10689-026-00575-y}
}
EUVIMED